Futura Medical PLC
17 July 2006
For immediate release 17 July 2006
Futura Medical plc
Announces FLD500 scale-up trials
Futura Medical plc (AIM: FUM) the pharmaceutical and medical device group that
develops innovative products for the sexual health market, announces pilot
scale-up trials of its Female Lubrication Device (FLD500) ahead of dossier
submission for the product's regulatory approval.
A successful outcome of these trials will facilitate the submission to EU
regulators during the first quarter of 2007 for FLD500's marketing
authorisation.
FLD500 is a standard DurexTM 'easy on' condom with a thin elastomer coating
containing an active compound on the outer surface to promote greater natural
lubrication and heightened pleasure for women. Currently up to 40% of condoms
sold within the UK are bought by women.
Following encouraging initial stability and compatibility results on the product
in laboratory studies, SSL International plc, the consumer healthcare brands
company that manufactures and distributes DurexTM, will be conducting trials
this month.
James Barder, Chief Executive of Futura, said: 'This is an important step
towards the submission of the regulatory dossier for FLD500 and will be the
first condom product targeted to improve the sex lives of women.'
For further information:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0) 1483 685 670
mail to: james.barder@futuramedical.co.uk www.futuramedical.co.uk
Media enquiries:
Buchanan Communications
Mark Court Tel: +44 (0) 20 7466 5000
Notes
Futura Medical plc
Futura Medical is a pharmaceutical drug and medical device group developing
innovative products for the sexual health market. The Company is developing a
portfolio of products and its strategy is to license their manufacture and
distribution to major pharmaceutical and healthcare groups. Futura's primary
focus is on over-the-counter products with particular appeal to men and women
who are reluctant to discuss potentially embarrassing sexual matters with their
doctors.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of
the London Stock Exchange.
For further details please visit www.futuramedical.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange